image description

Tag: TULIP-1

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] Read More

LRA Welcomes Positive Results with Anifrolumab for Reducing Lupus Flares

May 13, 2021 A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced flares in people with moderate to severe lupus while allowing lowered steroid use. The study was published in the professional journal Lupus by top lupus researchers, several of whom are leaders in the Lupus Clinical […] Read More